Ypsomed Holding AG (CHIX:YPSNZ) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:YPSNZ Ypsomed Holding AG CHIX:YPSNZ
87 GF Score
Price CHF383.00
GF Value CHF394.72
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ypsomed Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:YPSNZ
87GF Score
Ypsomed Holding AG CHIX:YPSNZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (CHIX:YPSNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF383.00 is trading 3% below its estimated GF Value™ of CHF394.72. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for CHIX:YPSNZ:

  • FFO:
  • GF Value™: CHF394.72 vs. price of CHF383.00 (3% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the CHIX:YPSNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
87GF Score

Get the complete analysis for CHIX:YPSNZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF383.00
Price
CHF394.72
GF Value